Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
China channel feed
Merck axes two of nine ADCs in pact with Kelun-Biotech
Last year
Deals
Pharma
BioNTech sends $70M to another ADC partner to go up against Daiichi Sankyo in HER3
Last year
Deals
Pharma
Sanofi adds another AI alliance, this time for biologics with Baidu CEO’s startup
Last year
Deals
AI
Updated: GSK taps Chinese partner to ramp up Shingrix sales in $3.05B deal, with option to expand to RSV
Last year
Deals
Chinese cell therapy biotech developing TIL therapies raises $60M Series B
Last year
Financing
ABVC BioPharma to break ground in China, advances 20% stake in Zhonghui real estate
Last year
R&D
Innoforce names Dewan Zeng as the new CEO
Last year
People
Manufacturing
Merck KGaA, MilliporeSigma make investments in the US and China manufacturing
Last year
Manufacturing
Updated: FDA to import more of common cancer drug from China after Indian site closure
Last year
Pharma
Manufacturing
BeiGene further invests in ADCs with solid tumor partner DualityBio, a BioNTech collaborator
3 years ago
Startups
Deals
WuXi Biologics seeks spinout, HK listing of bioconjugates-focused joint venture
3 years ago
Financing
Outsourcing
China approves BCMA CAR-T therapy for multiple myeloma, with Innovent beating Legend in race to be first
3 years ago
Cell/Gene Tx
CSPC to launch Paxlovid version in China; SEC charges ex-Pfizer employee with insider trading
3 years ago
Coronavirus
Law
Touting programs from Novartis, Laekna bags $100M in Hong Kong IPO while Merck-partnered Kelun seeks up to $208M
3 years ago
Financing
AstraZeneca ponders a China pharma spinoff to protect itself from geopolitical fallout — FT
3 years ago
Pharma
AstraZeneca enlists an upstart China biotech partner in the wake of an R&D setback
3 years ago
Deals
Bioregnum
Eccogene nabs $25M Series B for GLP-1 and a NASH drug candidate, as competitors lap the China biotech
3 years ago
Financing
Startups
Fosun Pharma to receive $100M+ via World Bank for facility in Ivory Coast
3 years ago
Pharma
Manufacturing
FDA inspection of China-based site making Coherus' potential new cancer drug ends with three observations
3 years ago
FDA+
China's market regulator fines, confiscates revenue from pharmas for monopolizing APIs for epinephrine
3 years ago
R&D
C4 Therapeutics gets $35M from Betta Pharmaceuticals to develop and market NSCLC drug in China
3 years ago
Deals
R&D
XtalPi inks $250M pact with Lilly after Pfizer success
3 years ago
Deals
AI
Innovent showcases topline PhII win for high-dose obesity drug in China
3 years ago
R&D
Roche hands Chinese biotech $70M for HER2 drug that can go to the brain
3 years ago
Deals
First page
Previous page
7
8
9
10
11
12
13
Next page
Last page